Your Article Summary
See Latest ArticlesEfficacy of Efalizumab in Psoriasis Patients Previously Treated with Tumour Necrosis Factor Blockers
Dermatology, 06/22/09
Costanzo A et al. - The data suggest that efalizumab can be successfully used in psoriasis patients when TNF blockers cannot efficiently control the disease due to lack or loss of response, or when they have to be interrupted for intolerance or adverse events.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Novel Therapies for Pemphigus Vulgaris: An Overview
Drugs & Aging, 09/21/09
Topical Pimecrolimus: A Review of its Use in the Management of Pediatric Atopic Dermatitis
Pediatric Drugs, 11/06/09
Clinical Importance of Purulence in Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections
Journal of the American Board of Family Medicine, 11/09/09
Today in Dermatologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Childhood melanoma
Clinics in Dermatology, 11/04/09
Unusual variants of malignant melanoma
Clinics in Dermatology, 11/06/09
A Multimarker Prognostic Assay for Primary Cutaneous Melanoma
Clinical Cancer Research, 11/06/09
Today in Psoriasis...keeping you current
Receive free subspecialty "5-minute updates" via email
Adalimumab for psoriasis patients who are non-responders to etanercept: open-label prospective evaluation
Journal of the European Academy of Dermatology and Venereology, 11/23/09
A practical approach to using methotrexate
Dermatology in Practice, 10/09/09
Therapeutic options for palmoplantar pustulosis
Clinical and Experimental Dermatology, 11/16/09